Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients.

Goicoechea M, Sanchez-Niño MD, Ortiz A, García de Vinuesa S, Quiroga B, Bernis C, Morales E, Fernández-Juarez G, de Sequera P, Verdalles U, Verde E, Luño J.

Prostaglandins Leukot Essent Fatty Acids. 2017 Oct;125:8-13. doi: 10.1016/j.plefa.2017.08.009. Epub 2017 Aug 24.

PMID:
28987723
2.

Cardiovascular risk prediction in chronic kidney disease patients.

Cedeño Mora S, Goicoechea M, Torres E, Verdalles Ú, Pérez de José A, Verde E, García de Vinuesa S, Luño J.

Nefrologia. 2017 May - Jun;37(3):293-300. doi: 10.1016/j.nefro.2016.10.002. Epub 2017 May 8. English, Spanish.

3.

Prevalence and characteristics of patients with resistant hypertension and chronic kidney disease.

Verdalles Ú, Goicoechea M, Garcia de Vinuesa S, Quiroga B, Galan I, Verde E, Perez de Jose A, Luño J.

Nefrologia. 2016 Sep - Oct;36(5):523-529. doi: 10.1016/j.nefro.2016.04.003. Epub 2016 Jul 18. English, Spanish.

4.

Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?

Verdalles U, García de Vinuesa S, Goicoechea M, Macías N, Santos A, Perez de Jose A, Verde E, Yuste C, Luño J.

Nephrology (Carlton). 2015 Aug;20(8):567-71. doi: 10.1111/nep.12475.

PMID:
25818266
5.

Interarm systolic blood pressure as a predictor of cardiovascular events in patients with chronic kidney disease.

Quiroga B, Galán I, García de Vinuesa S, Goicoechea M, Verdalles Ú, Luño J.

Nephrol Dial Transplant. 2015 May;30(5):801-6. doi: 10.1093/ndt/gfv059. Epub 2015 Mar 9.

PMID:
25753805
6.

Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.

Goicoechea M, Garcia de Vinuesa S, Verdalles U, Verde E, Macias N, Santos A, Pérez de Jose A, Cedeño S, Linares T, Luño J.

Am J Kidney Dis. 2015 Apr;65(4):543-9. doi: 10.1053/j.ajkd.2014.11.016. Epub 2015 Jan 13.

PMID:
25595565
7.

Evaluation of methods based on creatinine and cystatin C to estimate glomerular filtration rate in chronic kidney disease.

Vega A, García de Vinuesa S, Goicoechea M, Verdalles U, Martínez-Pueyo ML, Chacón A, Quiroga B, Luño J.

Int Urol Nephrol. 2014 Jun;46(6):1161-7. doi: 10.1007/s11255-013-0607-8. Epub 2013 Nov 22.

PMID:
24265040
8.

Cardiovascular events and mortality in chronic kidney disease (stages I-IV).

Quiroga B, Verdalles Ú, Reque J, García de Vinuesa S, Goicoechea M, Luño J.

Nefrologia. 2013;33(4):539-45. doi: 10.3265/Nefrologia.pre2013.May.11895. English, Spanish.

9.

Idiopathic fibrosis as the cause of obstructive uropathy.

Santos A, Quiroga B, Macías N, Goicoechea M, García-de Vinuesa S.

Nefrologia. 2013;33(3):439-40. doi: 10.3265/Nefrologia.pre2012.Sep.11705. English, Spanish. No abstract available.

10.

Hyporeninaemic hypoaldosteronism associated with membranous nephropathy: new hypotheses with regard to sodium retention in patients with proteinuria.

Quiroga B, García de Vinuesa S, Goicoechea M, Luño J.

Nefrologia. 2013;33(3):428-9. doi: 10.3265/Nefrologia.pre2013.Mar.11841. English, Spanish. No abstract available.

11.

[Vitamin D deficiency in a Spanish cohort of patients with chronic kidney disease].

Yuste C, García De Vinuesa S, Goicoechea M, Barraca D, Panizo N, Quiroga B, Luño J.

Med Clin (Barc). 2013 Oct 19;141(8):338-42. doi: 10.1016/j.medcli.2012.07.026. Epub 2012 Nov 23. Spanish.

PMID:
23182534
12.

Hypercalcemia as a side effect of potassium binding agents.

Arroyo D, Panizo N, García de Vinuesa S, Goicoechea M, Verdalles U, Luño J.

Nefrologia. 2012;32(5):655-8. doi: 10.3265/Nefrologia.pre2012.Jun.11500. English, Spanish.

13.

Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria.

Gutiérrez E, Zamora I, Ballarín JA, Arce Y, Jiménez S, Quereda C, Olea T, Martínez-Ara J, Segarra A, Bernis C, García A, Goicoechea M, García de Vinuesa S, Rojas-Rivera J, Praga M; Grupo de Estudio de Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN).

J Am Soc Nephrol. 2012 Oct;23(10):1753-60. Epub 2012 Sep 6.

14.

Calciphylaxis in end-stage renal disease patients.

Verdalles U, García de Vinuesa S, Luño J.

Nephrol Dial Transplant. 2012 Sep;27(9):3663; author reply 3663-4. doi: 10.1093/ndt/gfs271. Epub 2012 Jul 17. No abstract available.

PMID:
22805222
15.

Intraindividual interleukin-6 variations on the cardiovascular prognosis of patients with chronic renal disease.

Goicoechea M, Quiroga B, García de Vinuesa S, Verdalles U, Reque J, Panizo N, Arroyo D, Santos A, Macías N, Luño J.

Ren Fail. 2012;34(8):1002-9. doi: 10.3109/0886022X.2012.696469. Epub 2012 Jun 29.

PMID:
22746155
16.

Renal infarction in patient with long-standing ventricular aneurysm.

Quiroga B, Santos A, Verdalles U, Reque J, García de Vinuesa S, Goicoechea M, Pérez de José A, Macías N, Luño J.

Nefrologia. 2012;32(2):233-4. doi: 10.3265/Nefrologia.pre2012.Feb.11377. English, Spanish. No abstract available.

17.

Chronic kidney disease progression in patients with autosomal dominant polycystic kidney disease.

Panizo N, Goicoechea M, García de Vinuesa S, Arroyo D, Yuste C, Rincón A, Verdalles U, Ruiz-Caro C, Quiroga B, Luño J.

Nefrologia. 2012;32(2):197-205. doi: 10.3265/Nefrologia.pre2011.Dec.11177. Epub 2012 Jan 27. English, Spanish.

18.

Effects of pentoxifylline on inflammatory parameters in chronic kidney disease patients: a randomized trial.

Goicoechea M, García de Vinuesa S, Quiroga B, Verdalles U, Barraca D, Yuste C, Panizo N, Verde E, Muñoz MA, Luño J.

J Nephrol. 2012 Nov-Dec;25(6):969-75. doi: 10.5301/jn.5000077.

PMID:
22241639
19.

[Cardiac markers in different degrees of chronic kidney disease: influence of inflammation and previous heart disease].

Quiroga B, Goicoechea M, García de Vinuesa S, Verde E, Verdalles U, Yuste C, Reque J, Luño J.

Med Clin (Barc). 2012 Jun 30;139(3):98-102. doi: 10.1016/j.medcli.2011.05.014. Epub 2011 Jul 31. Spanish.

PMID:
21807382
20.

[Renal function in patients with metabolic syndrome attending primary care].

Abellán Alemán J, Prieto Díaz MÁ, Leal Hernández M, García de Vinuesa S, Luño Fernández J; Estudio SMAPyH.

Aten Primaria. 2011 Jun;43(6):325-6. doi: 10.1016/j.aprim.2010.05.018. Epub 2011 Jan 6. Spanish. No abstract available.

Supplemental Content

Loading ...
Support Center